AstraZeneca

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

CEO

Pascal Soriot

CEOPascal Soriot

Employees

94,300

Employees94,300

Headquarters

Cambridge, Cambridgeshire

HeadquartersCambridge, Cambridgeshire

Founded

1992

Founded1992

Employees

94,300

Employees94,300

AZN Key Statistics

Market cap

221.27B

Market cap221.27B

Price-Earnings ratio

28.02

Price-Earnings ratio28.02

Dividend yield

2.16%

Dividend yield2.16%

Average volume

5.32M

Average volume5.32M

High today

$70.69

High today$70.69

Low today

$68.05

Low today$68.05

Open price

$70.02

Open price$70.02

Volume

4.04M

Volume4.04M

52 Week high

$87.68

52 Week high$87.68

52 Week low

$61.24

52 Week low$61.24

AZN News

TipRanks 1d

AstraZeneca’s Enhertu Shows Promise in Early-Stage Breast Cancer Trial

AstraZeneca ( (GB:AZN) ) has shared an update. AstraZeneca and Daiichi Sankyo announced positive results from the DESTINY-Breast11 Phase III trial, showing tha...

TipRanks 2d

Berenberg says pharma ’emerging from the pill penalty box’

Berenberg says the pharma industry is “emerging from the pill penalty box” after the Trump administration removed the “pill penalty” within the Medicare prescri...

Benzinga 6d

AstraZeneca's Triple-Combination Therapy Breztri Hits Primary Goals In Two Pivotal Studies For Asthma

On Friday, AstraZeneca Plc AZN reported topline data from Phase 3 KALOS and LOGOS trials in patients with uncontrolled asthma. KALOS and LOGOS trials assessed...

Analyst ratings

91%

of 32 ratings

Buy

90.6%

Hold

9.4%

Sell

More AZN News

TipRanks 6d

AstraZeneca announces KALOS, LOGOS trials met all primary endpoints

Results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s (AZN) fixed-dose triple-combination therapy Bre...

TipRanks 7d

AstraZeneca Director Invests in Company Shares

AstraZeneca ( (GB:AZN) ) just unveiled an announcement. AstraZeneca announced that Karen Knudsen, a Non-Executive Director, purchased 1,400 American Depositary...